---
schema_version: "secwatch.filing_event.v1"
accession: "0001213900-22-065828"
form_type: "8-K"
ticker: "RAPH"
cik: "0001415397"
company_name: "Raphael Pharmaceutical Inc."
filed_at: "2022-10-24T23:59:59+00:00"
generated_at: "2026-06-23T01:36:40.031467+00:00"
event_type: "other_material"
sentiment: "positive"
materiality_score: 0.45
calibrated_materiality_score: 0.45
confidence: "high"
source: SEC EDGAR
---

# Raphael Pharmaceutical accepted for OTCQB up-list, to trade under 'RAPH'

## Summary
- Application submitted September 1, 2022; notified of acceptance on October 7, 2022.
- Will trade on OTCQB under ticker symbol 'RAPH' after trading approval from OTC Markets.
- Company has paid required fees and increased financial transparency to meet OTCQB standards.
- Management believes the up-list better positions the company for a greater growth trajectory.

## SEC filing metadata
- accession: 0001213900-22-065828
- form_type: 8-K
- ticker: RAPH
- cik: 0001415397
- company_name: Raphael Pharmaceutical Inc.
- filed_at: 2022-10-24T23:59:59+00:00
- event_type: other_material
- sentiment: positive
- materiality_score: 0.45
- calibrated_materiality_score: 0.45
- confidence: high
- sec_items: 8.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1415397/000121390022065828/0001213900-22-065828-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1415397/000121390022065828/ea167503-8k_raphael.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001213900-22-065828
- JSON: https://secwatch.observer/filing/0001213900-22-065828.json
- Plain text: https://secwatch.observer/filing/0001213900-22-065828.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.